March 21, 2023 03:46 PM EDT

FDA warns Procter & Gamble over NyQuil label's ingredient listings

Tyler Patchen

News Reporter

The FDA on Tuesday released a warning letter sent earlier this month to the Mason, OH-based site of Procter & Gamble Manufactura, raising questions about …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA warns Procter & Gamble over NyQuil label's ingredient listings

Tyler Patchen

News Reporter

Sign up to read this article for free.

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

New fund will pressure flailing biotechs, as investor frustration boils over

FDA chief Makary talks expediting drug approvals, RIFs and the abortion pill

Akeso shares new data suggesting it can beat Keytruda on survival, wins China approval

AbbVie commits $10B to expand US footprint with the threat of tariffs ahead

Caribou lays off 32% of staff, cuts lupus cell therapy program before first patient

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

FDA warns Proc­ter & Gam­ble over NyQuil la­bel's in­gre­di­ent list­ings

News Reporter

Sign up to read this article for free.

Gondolabio

Palo Alto, CA, USA

FDA warns Procter & Gamble over NyQuil label's ingredient listings